Common Contracts

3 similar Securities Purchase Agreement contracts by Oric Pharmaceuticals, Inc., Relay Therapeutics, Inc.

ORIC PHARMACEUTICALS, INC. SECURITIES PURCHASE AGREEMENT
Securities Purchase Agreement • May 28th, 2025 • Oric Pharmaceuticals, Inc. • Pharmaceutical preparations • New York

The undersigned understands that ORIC Pharmaceuticals, Inc. (the “Company”) is party to that certain Securities Purchase Agreement dated on or about the date hereof (the “Purchase Agreement”) providing for the sale and issuance of the Securities. Capitalized terms used herein and not otherwise defined shall have the meanings set forth in the Purchase Agreement.

RELAY THERAPEUTICS, INC. SECURITIES PURCHASE AGREEMENT
Securities Purchase Agreement • January 8th, 2024 • Relay Therapeutics, Inc. • Biological products, (no disgnostic substances) • New York

This Securities Purchase Agreement (the “Agreement”) is made as of January 8, 2024 (the “Effective Date”), by and among Relay Therapeutics, Inc., a Delaware corporation (the “Company”), and the purchasers whose name and address is set forth on the signature pages hereof (the “Purchaser”).

ORIC PHARMACEUTICALS, INC. SECURITIES PURCHASE AGREEMENT
Securities Purchase Agreement • June 27th, 2023 • Oric Pharmaceuticals, Inc. • Pharmaceutical preparations • New York

This Securities Purchase Agreement (the “Agreement”) is made as of June 24, 2023 (the “Effective Date”), by and among ORIC Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and the purchasers whose names and addresses are set forth on the signature pages hereof (each, a “Purchaser” and, collectively, the “Purchasers”).